Freestone Capital Holdings’s Takeda Pharmaceutical TAK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-48,624	Closed	-$696K	–	571
2022 Q1	$696K	Buy	48,624 +35,928	+283%	+$528K	0.03%	294
2021 Q4	$173K	Buy	+12,696	New	+$178K	0.01%	481
2021 Q3	–	Sell	-11,016	Closed	-$185K	–	439
2021 Q2	$185K	Sell	11,016 -3,467	-24%	-$59K	0.01%	398
2021 Q1	$264K	Sell	14,483 -59,805	-81%	-$1.08M	0.01%	345
2020 Q4	$1.35M	Sell	74,288 -76,407	-51%	-$1.34M	0.08%	180
2020 Q3	$2.69M	Sell	150,695 -28,019	-16%	-$510K	0.18%	122
2020 Q2	$3.2K	Sell	178,714 -16,101	-8%	-$289K	0.04%	117
2020 Q1	$2.96K	Buy	194,815 +72,227	+59%	+$1.31M	0.06%	108
2019 Q4	$2.42K	Buy	122,588 +3,594	+3%	+$68.8K	0.05%	160
2019 Q3	$2.05K	Buy	118,994 +22,539	+23%	+$390K	0.05%	172
2019 Q2	$1.71K	Buy	96,455 +16,642	+21%	+$303K	0.04%	176
2019 Q1	$1.63M	Buy	79,813 +49,691	+165%	+$1,000K	0.1%	173
2018 Q4	$507K	Buy	+30,122	New	+$509K	0.03%	287